Standards › ASF Health Standards v10 › Standard 57
Standard 57
Radiotherapy
Radiotherapy: each course justified and independently checked before the first fraction, patient and site verified before every treatment, treatment machines under quality assurance, staff and visitors protected, and patients informed about side effects and follow-up..
Each criterion is shown in three settings: Humanitarian settings, Transition and fragile, and Standard. In standard settings, every criterion is Must.
Training colours: red means essential, green recommended, yellow optional. Each course shows its level for each setting: humanitarian, transition and fragile, and standard.
57.1The Radiotherapy Plan Is Justified and Independently Checked Before the First TreatmentHumanitarian settings: MustTransition and fragile: MustStandard: Must
Every course of radiotherapy has a documented justification and a prescription signed by the clinician. The treatment plan is checked independently by a second qualified person before the first fraction is given.
Why it matters.
How the surveyor verifies this criterion
Sample. Review the justification, prescription and plan check records for every course of radiotherapy started in the last 6 months.
1. The plan is checked by a second qualified person before the first fraction.
Method. Check each sampled plan for the independent check entry dated before the first fraction.
Evidence to show. Treatment plan verification record (RTH-FRM-001).
Pass when. Every sampled plan has an independent check recorded before the first fraction.
2. Any discrepancy found in the check is resolved and the plan is re-checked.
Method. Check each recorded discrepancy for the correction and the re-check.
Evidence to show. Treatment plan verification record (RTH-FRM-001).
Pass when. Every recorded discrepancy has a correction and a re-check.
Immediate fail (any one means the criterion is not met). A plan with the wrong target volume starts treatment without an independent check, and the error is found after ten fractions.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Nurse (ISCO 2221) | Completes the Treatment plan verification before the first fraction (RTH-SOP-001); treatment plan verification record | Must |
| Manager (ISCO 1342) | Checks the criterion at each review | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| RTH-SOP-001 · Treatment plan verification before the first fraction | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| RTH-FRM-001 · Treatment plan verification record | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Oncology & Infusion Therapy Safety Endorsement (AMB-11) | Manager; Nurse |
References
- International Atomic Energy Agency (n.d.). Radiation Protection and Safety in Medical Uses of Ionizing Radiation. Used for: Justification and independent checking of treatment https://news.gmj.ge/guideline/radiation-protection-and-safety-in-medical-uses-of-ionizing-radiation/
- WHO/IAEA (2021). Technical Specifications of Radiotherapy Equipment for Cancer Treatment. Used for: Radiotherapy equipment for treatment planning https://news.gmj.ge/guideline/technical-specifications-of-radiotherapy-equipment-for-cancer-treatment/
57.2Patient Identity and Treatment Site Are Verified Before Every FractionHumanitarian settings: MustTransition and fragile: MustStandard: Must
Before every fraction, the patient identity, the treatment site and the set-up are verified against the plan, and the treatment is paused for a check when the set-up differs from the plan.
Why it matters.
How the surveyor verifies this criterion
Sample. Observe a sample of treatment sessions on several days and audit the daily verification records for the sample period.
1. Patient identity is verified before every fraction.
Method. Observe the identity check for each sampled fraction against the record.
Evidence to show. Daily treatment verification record (RTH-FRM-002).
Pass when. Every observed fraction has identity verified.
2. Treatment site and set-up are verified against the plan.
Method. Check the set-up record for each sampled fraction against the plan.
Evidence to show. Daily treatment verification record (RTH-FRM-002).
Pass when. Every sampled fraction has the set-up verified against the plan.
3. Treatment is paused for review when the set-up differs from the plan.
Method. Check each sampled set-up difference for the pause and the review recorded.
Evidence to show. Patient identity and site verification before each fraction (RTH-SOP-002).
Pass when. Every sampled set-up difference has a pause and review recorded.
Immediate fail (any one means the criterion is not met). A patient is treated on the wrong side because the set-up was not checked against the plan on that day.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Nurse (ISCO 2221) | Completes the Patient identity and site verification before each fraction (RTH-SOP-002); daily treatment verification record | Must |
| Manager (ISCO 1342) | Maintains the Patient identity and site verification before each fraction | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| RTH-SOP-002 · Patient identity and site verification before each fraction | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| RTH-FRM-002 · Daily treatment verification record | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Oncology & Infusion Therapy Safety Endorsement (AMB-11) | Manager; Nurse |
References
In process of development. Will be available soon.
57.3Treatment Equipment Is Checked by a Quality Assurance ProgrammeHumanitarian settings: MinimumTransition and fragile: MustStandard: Must
Linear accelerators and other treatment equipment are checked on a documented quality assurance schedule, including output and safety interlocks. A machine that fails a check is taken out of clinical use until it is repaired and re-tested.
Why it matters.
How the surveyor verifies this criterion
Sample. Review the quality assurance register and the output and safety checks for every treatment machine in the last 12 months.
1. Each machine is checked on the documented schedule.
Method. Compare each machine check date with the schedule.
Evidence to show. Machine quality assurance register (RTH-REG-001).
Pass when. Every scheduled check is recorded on time.
2. Output and safety interlocks are checked and within tolerance.
Method. Check each recorded output and interlock result against the tolerance.
Evidence to show. Machine quality assurance register (RTH-REG-001).
Pass when. Every recorded result is within tolerance or the machine is recorded as out of use.
3. A machine that fails a check is taken out of use until re-tested.
Method. Check each failed result for the out-of-use record and the re-test.
Evidence to show. Machine quality assurance register (RTH-REG-001).
Pass when. Every failed result has the out-of-use entry and a passed re-test before return.
Immediate fail (any one means the criterion is not met). A linear accelerator with a faulty interlock treats patients for a week before the failure is noticed.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Secretary (ISCO 3344) | Keeps the Linear accelerator quality assurance (RTH-SOP-003); machine quality assurance register | Must |
| Manager (ISCO 1342) | Checks the criterion at each review | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| RTH-SOP-003 · Linear accelerator quality assurance | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| RTH-REG-001 · Machine quality assurance register | Secretary (ISCO 3344) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Oncology & Infusion Therapy Safety Endorsement (AMB-11) | Manager; Nurse |
References
- WHO/IAEA (2021). Technical Specifications of Radiotherapy Equipment for Cancer Treatment. Used for: Quality assurance of treatment equipment https://news.gmj.ge/guideline/technical-specifications-of-radiotherapy-equipment-for-cancer-treatment/
- WHO/IAEA (2023). Sustainable management of radiotherapy facilities and equipment. Used for: Life-cycle maintenance of radiotherapy equipment https://news.gmj.ge/guideline/sustainable-management-of-radiotherapy-facilities-and-equipment/
57.4Staff and Visitors Are Protected by Shielding, Controlled Areas and DosimetryHumanitarian settings: MinimumTransition and fragile: MediumStandard: Must
Treatment rooms have controlled areas and shielding that meet the design, and staff wear personal dosimeters whose readings are reviewed at the set interval. Visitors and pregnant staff are managed under a written policy.
Why it matters.
How the surveyor verifies this criterion
Sample. Review the dosimetry records and the shielding and controlled area checks for the last 12 months.
1. Staff wear personal dosimeters and the readings are reviewed at the set interval.
Method. Compare each sampled staff member with the dosimetry register and the review dates.
Evidence to show. Radiation protection in the treatment room (RTH-POL-001).
Pass when. Every sampled staff member has readings reviewed at the interval.
2. Treatment rooms have shielding and controlled areas that meet the design.
Method. Inspect the shielding and the controlled area signs on the sampled days.
Evidence to show. Radiation protection in the treatment room (RTH-POL-001).
Pass when. Every inspected room has the shielding and controlled area in place.
3. Pregnant staff and visitors are managed under the written policy.
Method. Check the records for each pregnant staff member and visitor entry in the sample.
Evidence to show. Radiation protection in the treatment room (RTH-POL-001).
Pass when. Every sampled case follows the written policy.
Immediate fail (any one means the criterion is not met). A staff member receives a dose above the set limit, and the reading is not reviewed for six months.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the Personal dosimetry register (RTH-REG-002); radiation protection in the treatment room | Medium |
| Manager (ISCO 1342) | Checks the criterion at each review | Medium |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| RTH-REG-002 · Personal dosimetry register | Secretary (ISCO 3344) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
| RTH-POL-001 · Radiation protection in the treatment room | Chief executive (ISCO 1120) | Governing body members | N/A | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Oncology & Infusion Therapy Safety Endorsement (AMB-11) | Manager; Nurse |
References
- International Atomic Energy Agency (n.d.). Radiation Protection and Safety in Medical Uses of Ionizing Radiation. Used for: Shielding, controlled areas and dosimetry https://news.gmj.ge/guideline/radiation-protection-and-safety-in-medical-uses-of-ionizing-radiation/
- International Atomic Energy Agency (n.d.). Radiation Protection and Safety of Radiation Sources: International Basic Safety Standards. Used for: Radiation protection of staff and the public https://news.gmj.ge/guideline/radiation-protection-and-safety-of-radiation-sources-international-basic-safety-standards/
57.5Patients Receive Written Information on Side Effects and Follow-UpHumanitarian settings: MinimumTransition and fragile: MediumStandard: Must
Each patient receives written information on expected side effects, skin care and warning signs before the first fraction, with a follow-up review of toxicity recorded during and after treatment.
Why it matters.
How the surveyor verifies this criterion
Sample. Review the written information and toxicity follow-up records for a sample of patients who started treatment in the last 6 months.
1. Toxicity is reviewed during and after treatment and recorded.
Method. Check each sampled patient for the toxicity review entries during and after treatment.
Evidence to show. Treatment toxicity and follow-up record (RTH-FRM-003).
Pass when. Every sampled patient has toxicity reviewed and recorded during and after treatment.
2. Patients with severe toxicity are reviewed the same week.
Method. Check each sampled severe toxicity for the review date.
Evidence to show. Treatment toxicity and follow-up record (RTH-FRM-003).
Pass when. Every sampled severe toxicity was reviewed within the week.
Immediate fail (any one means the criterion is not met). A patient with severe skin reaction is not reviewed, and the wound becomes infected.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Nurse (ISCO 2221) | Completes the Treatment toxicity and follow-up record | Medium |
| Manager (ISCO 1342) | Checks the criterion at each review | Medium |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| RTH-FRM-003 · Treatment toxicity and follow-up record | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Oncology & Infusion Therapy Safety Endorsement (AMB-11) | Manager; Nurse |
References
In process of development. Will be available soon.
Who is responsible for Standard 57
Each criterion names the positions responsible for it. Every position links to its own terms of reference.
| Criterion | Responsible | Supports |
|---|---|---|
| 57.1 The Radiotherapy Plan Is Justified and Independently Checked Before the First Treatment | Radiation oncologist Medical physicist |
Radiotherapy technologist |
| 57.2 Patient Identity and Treatment Site Are Verified Before Every Fraction | Radiotherapy technologist Radiation oncologist |
|
| 57.3 Treatment Equipment Is Checked by a Quality Assurance Programme | Medical physicist | Radiation protection officer |
| 57.4 Staff and Visitors Are Protected by Shielding, Controlled Areas and Dosimetry | Radiation protection officer | Medical physicist |
| 57.5 Patients Receive Written Information on Side Effects and Follow-Up | Radiation oncologist | Health educator / health promotion officer |
Role details: reporting, supervision and training
Training shown is the general recommendation. Role-specific training is set in the next improvement round.
| Role | Reports to | Supervises | Recommended training |
|---|---|---|---|
| Radiation protection officer | Risk manager | None | Facility induction; safeguarding adults (general recommendation) |
| Radiation oncologist | Head of department (per specialty) | None | Facility induction; safeguarding adults (general recommendation) |
| Health educator / health promotion officer | Head of department (per specialty) | None | Facility induction; safeguarding adults (general recommendation) |
| Radiotherapy technologist | Head of department (per specialty) | None | Facility induction; safeguarding adults (general recommendation) |
| Medical physicist | Head of department (per specialty) | None | Facility induction; safeguarding adults (general recommendation) |
Questions and answers
The criterion text is the authority. These answers summarise it.
Who does Standard 64 apply to?
Radiotherapy services that treat cancer with radiation, including the planning, delivery, equipment and staff protection around each course of treatment.
What do the colours mean for this standard?
Red (Must) is required. Green (Medium) is recommended. Yellow (Minimum) is the lowest acceptable level in humanitarian settings. Standard setting is Must on every criterion.
Is each radiotherapy course checked before treatment starts?
Yes. Under 57.1 every course has a documented justification and a clinician-signed prescription, and the plan is checked by a second qualified person before the first fraction.
How is the patient checked before each treatment?
Under 57.2 before every fraction the patient, the treatment site and the set-up are verified against the plan, and treatment pauses if the set-up differs.
How is the treatment machine checked?
Under 57.3 linear accelerators and other equipment are checked on a documented quality assurance schedule, and a machine that fails is taken out of use.
How are staff and visitors protected?
Under 57.4 treatment rooms have shielding and controlled areas, staff wear personal dosimeters reviewed at a set interval, and visitors and pregnant staff are protected.
What do patients receive?
Under 57.5 each patient gets written information on side effects, skin care and warning signs before the first fraction, and toxicity is reviewed during and after treatment.
Guidelines for this standard
11 guideline(s) are held in the GMJ Guidelines Library and listed here. Each link opens the full guideline on news.gmj.ge. The complete library, grouped by standard, is at Guidelines.
- National generic radiotherapy consent form (written patient information) (Royal College of Radiologists)
- Towards Safer Radiotherapy (Royal College of Radiologists, SCoR, IPEM, NPSA et al.)
- Radiation Protection and Safety of Radiation Sources: International Basic Safety Standards (International Atomic Energy Agency)
- Radiation Protection and Safety in Medical Uses of Ionizing Radiation (International Atomic Energy Agency)
- Technical specifications of radiotherapy equipment for cancer treatment (World Health Organization)
- Technical Specifications of Radiotherapy Equipment for Cancer Treatment (World Health Organization)
- Sustainable management of radiotherapy facilities and equipment (World Health Organization)
- Sustainable management of radiotherapy facilities and equipment (World Health Organization)
- Technical specifications for health facility based medical oxygen systems (World Health Organization)
- Technical specifications of medical devices for the case management of COVID-19 in healthcare settings (Pan American Health Organization)
- Requirements and technical specifications of personal protective equipment (PPE) for the novel coronavirus (2019-nCoV) in healthcare settings (Pan American Health Organization)